CS Capital is an investment firm that specializes in providing comprehensive investment management services. The firm primarily focuses on Series B investment rounds, supporting companies with substantial growth potential. Their investment strategy encompasses various sectors, with a notable emphasis on biotherapeutics, as evidenced by their involvement in Tavotek Biotherapeutics, which has raised $35 million.
CS Capital's portfolio includes prominent companies like Tavotek Biotherapeutics, highlighting their commitment to innovative and high-growth industries. The firm's key partners and decision-makers bring extensive expertise and industry connections, enhancing their ability to provide strategic guidance and support to their portfolio companies. CS Capital's investment philosophy centers on fostering long-term growth and value creation, offering unique value-add services such as strategic advisory and operational support to help their investments thrive.
CS Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Series B2 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.
